ProductProductWhat are Generics?
Hyzaar
view photo
Generic Hyzaar Losartan - Hydrochlorothiazide 50mg + 12.5mg

Generic Hyzaar is used for treating high blood pressure. It may be used to decrease the risk of stroke in certain patients with high blood pressure.Generic Hyzaar is used for treating high blood pressure. It may be used to decrease the risk of stroke in certain patients with high blood pressure.


Hypertension


PackagePricePer pillSavingsOrder
50mg + 12.5mg × 30 pills$48.20$ 1.61 
50mg + 12.5mg × 60 pills$92.40$ 1.54  $4.00
50mg + 12.5mg × 90 pills$117.60$ 1.31  $27.00
50mg + 12.5mg × 120 pills$142.80$ 1.19  $50.00
50mg + 12.5mg × 180 pills$193.20$ 1.07  $96.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
I received a partial shipment yesterday.
The pills have always worked very well...as expected.
That's why I ordered from you again this year...just like last year.
In fact, yours work better than the 50 mg brand name pills I still have!!
An since your pills are scored (unlike the brand name ones that I have to use a knife to split), I can easily lower the dosage to 25 mg...which is all I need.
Thank you for a great product at a reasonable price!
Read more »Read more »
NewsNews
    1 Unexcitingly Good Dividend Play - DailyFinance
    1 Unexcitingly Good Dividend PlayDailyFinanceRight now it's Merck's heart drugs Cozaar and Hyzaar, which plummeted 21% in the first quarter
    Merck: Will Singulair Expiration Sink Its Stock? - Citybizlist (press release)
    Merck: Will Singulair Expiration Sink Its Stock?Citybizlist (press release)The growth in pharmaceuticals was impacted by large drops in revenues from Remicade, Cozaar and Hyzaar
    Merck Posts Big Q1 Profit Jump on Lower Charges - ABC News
    ABC NewsMerck Posts Big Q1 Profit Jump on Lower ChargesABC NewsTogether, they brought in $1
    Drugmaker Merck's Q1 profit jumps 67 pct. on lower spending, despite lower ... - Washington Post
    BloombergDrugmaker Merck's Q1 profit jumps 67 pct
    Strong profit growth and Zetia patent win for Merck & Co - Pharma Times
    Strong profit growth and Zetia patent win for Merck & CoPharma TimesRevenues from the antihypertensives Cozaar (losartan) and Hyzaar (losartan plus hydrochlorothiazide) fell 21% to $336 million, due to generic competition
Live support Online Chat


Our billing is certified by
Secure shopping certificates